Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS-CoV-2) is associated with a heightened risk of thrombotic events. 1 We sought to …

Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

Background Infection with coronavirus SARS-CoV-2, causing COVID-19 disease, leads to
inflammation and a prothrombotic state. Objective This rapid systematic review aims to …

The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also
known as COVID-19, is a single-stranded enveloped RNA virus that created a Public Health …

Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …

Objective To assess the associations between coronavirus disease 2019 (COVID-19)
infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep …

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease. Bilateral
pneumonia, acute respiratory failure, systemic inflammation, endothelial dysfunction and …